Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Detected renal cysts are tips of the iceberg in adults with ADPKD.

Grantham JJ, Mulamalla S, Grantham CJ, Wallace DP, Cook LT, Wetzel LH, Fields TA, Bae KT.

Clin J Am Soc Nephrol. 2012 Jul;7(7):1087-93. doi: 10.2215/CJN.00900112. Epub 2012 May 10.

2.

Evidence of extraordinary growth in the progressive enlargement of renal cysts.

Grantham JJ, Cook LT, Wetzel LH, Cadnapaphornchai MA, Bae KT.

Clin J Am Soc Nephrol. 2010 May;5(5):889-96. doi: 10.2215/CJN.00550110. Epub 2010 Apr 1.

3.

Novel methodology to evaluate renal cysts in polycystic kidney disease.

Bae KT, Sun H, Lee JG, Bae K, Wang J, Tao C, Chapman AB, Torres VE, Grantham JJ, Mrug M, Bennett WM, Flessner MF, Landsittel DP; Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease.

Am J Nephrol. 2014;39(3):210-7. doi: 10.1159/000358604. Epub 2014 Feb 22.

4.

Segmentation of individual renal cysts from MR images in patients with autosomal dominant polycystic kidney disease.

Bae K, Park B, Sun H, Wang J, Tao C, Chapman AB, Torres VE, Grantham JJ, Mrug M, Bennett WM, Flessner MF, Landsittel DP, Bae KT; Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP).

Clin J Am Soc Nephrol. 2013 Jul;8(7):1089-97. doi: 10.2215/CJN.10561012. Epub 2013 Mar 21.

5.

Magnetic resonance imaging evaluation of hepatic cysts in early autosomal-dominant polycystic kidney disease: the Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease cohort.

Bae KT, Zhu F, Chapman AB, Torres VE, Grantham JJ, Guay-Woodford LM, Baumgarten DA, King BF Jr, Wetzel LH, Kenney PJ, Brummer ME, Bennett WM, Klahr S, Meyers CM, Zhang X, Thompson PA, Miller JP; Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP).

Clin J Am Soc Nephrol. 2006 Jan;1(1):64-9. Epub 2005 Oct 26.

6.

Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) cohort.

Chapman AB, Guay-Woodford LM, Grantham JJ, Torres VE, Bae KT, Baumgarten DA, Kenney PJ, King BF Jr, Glockner JF, Wetzel LH, Brummer ME, O'Neill WC, Robbin ML, Bennett WM, Klahr S, Hirschman GH, Kimmel PL, Thompson PA, Miller JP; Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease cohort.

Kidney Int. 2003 Sep;64(3):1035-45.

7.

Magnetic resonance imaging of kidney and cyst volume in children with ADPKD.

Cadnapaphornchai MA, Masoumi A, Strain JD, McFann K, Schrier RW.

Clin J Am Soc Nephrol. 2011 Feb;6(2):369-76. doi: 10.2215/CJN.03780410. Epub 2010 Nov 29.

8.

Novel approach to estimate kidney and cyst volumes using mid-slice magnetic resonance images in polycystic kidney disease.

Bae KT, Tao C, Wang J, Kaya D, Wu Z, Bae JT, Chapman AB, Torres VE, Grantham JJ, Mrug M, Bennett WM, Flessner MF, Landsittel DP; Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP).

Am J Nephrol. 2013;38(4):333-41. doi: 10.1159/000355375. Epub 2013 Oct 5.

9.

Autosomal dominant polycystic kidney disease: MR imaging evaluation using current techniques.

Mosetti MA, Leonardou P, Motohara T, Kanematsu M, Armao D, Semelka RC.

J Magn Reson Imaging. 2003 Aug;18(2):210-5.

PMID:
12884334
10.

Comparison of MRI segmentation techniques for measuring liver cyst volumes in autosomal dominant polycystic kidney disease.

Farooq Z, Behzadi AH, Blumenfeld JD, Zhao Y, Prince MR.

Clin Imaging. 2018 Jan - Feb;47:41-46. doi: 10.1016/j.clinimag.2017.07.004. Epub 2017 Jul 12.

PMID:
28846875
11.

Pancreatic Cysts in Autosomal Dominant Polycystic Kidney Disease: Prevalence and Association with PKD2 Gene Mutations.

Kim JA, Blumenfeld JD, Chhabra S, Dutruel SP, Thimmappa ND, Bobb WO, Donahue S, Rennert HE, Tan AY, Giambrone AE, Prince MR.

Radiology. 2016 Sep;280(3):762-70. doi: 10.1148/radiol.2016151650. Epub 2016 Apr 5.

12.

Volumetric determination of progression in autosomal dominant polycystic kidney disease by computed tomography.

Sise C, Kusaka M, Wetzel LH, Winklhofer F, Cowley BD, Cook LT, Gordon M, Grantham JJ.

Kidney Int. 2000 Dec;58(6):2492-501.

13.

Cisterna chyli in autosomal dominant polycystic kidney disease.

Thimmappa ND, Blumenfeld JD, Cerilles MA, Dunning A, Donahue SL, Bobb WO, Zhang HL, Prince MR.

J Magn Reson Imaging. 2015 Jan;41(1):142-8. doi: 10.1002/jmri.24527. Epub 2014 Jan 27.

PMID:
24470398
14.

Imaging features of tuberous sclerosis complex with autosomal-dominant polycystic kidney disease: a contiguous gene syndrome.

Back SJ, Andronikou S, Kilborn T, Kaplan BS, Darge K.

Pediatr Radiol. 2015 Mar;45(3):386-95. doi: 10.1007/s00247-014-3147-1. Epub 2014 Oct 30.

PMID:
25355409
15.

Intracystic magnetic resonance imaging in patients with autosomal dominant polycystic kidney disease: features of severe cyst infection in a case-control study.

Suwabe T, Ubara Y, Ueno T, Hayami N, Hoshino J, Imafuku A, Kawada M, Hiramatsu R, Hasegawa E, Sawa N, Saitoh S, Okuda I, Takaichi K.

BMC Nephrol. 2016 Nov 9;17(1):170.

16.

Rapid MR imaging detection of renal cysts: age-based standards.

Nascimento AB, Mitchell DG, Zhang XM, Kamishima T, Parker L, Holland GA.

Radiology. 2001 Dec;221(3):628-32.

PMID:
11719656
17.

Volume progression in polycystic kidney disease.

Grantham JJ, Torres VE, Chapman AB, Guay-Woodford LM, Bae KT, King BF Jr, Wetzel LH, Baumgarten DA, Kenney PJ, Harris PC, Klahr S, Bennett WM, Hirschman GN, Meyers CM, Zhang X, Zhu F, Miller JP; CRISP Investigators.

N Engl J Med. 2006 May 18;354(20):2122-30.

18.

Magnetic resonance measurements of renal blood flow and disease progression in autosomal dominant polycystic kidney disease.

Torres VE, King BF, Chapman AB, Brummer ME, Bae KT, Glockner JF, Arya K, Risk D, Felmlee JP, Grantham JJ, Guay-Woodford LM, Bennett WM, Klahr S, Meyers CM, Zhang X, Thompson PA, Miller JP; Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP).

Clin J Am Soc Nephrol. 2007 Jan;2(1):112-20. Epub 2006 Nov 2.

19.

Association of kidney and cysts dimensions with anthropometric and biochemical parameters in patients with ADPKD.

Pietrzak-Nowacka M, Safranow K, Palacz J, Gołembiewska E, Marchelek-Myśliwiec M, Ciechanowski K.

Ren Fail. 2015 Jun;37(5):798-803. doi: 10.3109/0886022X.2015.1033608. Epub 2015 Apr 14.

PMID:
25869055
20.

Rationale and design of the TEMPO (Tolvaptan Efficacy and Safety in Management of Autosomal Dominant Polycystic Kidney Disease and its Outcomes) 3-4 Study.

Torres VE, Meijer E, Bae KT, Chapman AB, Devuyst O, Gansevoort RT, Grantham JJ, Higashihara E, Perrone RD, Krasa HB, Ouyang JJ, Czerwiec FS.

Am J Kidney Dis. 2011 May;57(5):692-9. doi: 10.1053/j.ajkd.2010.11.029. Epub 2011 Feb 17.

PMID:
21333426

Supplemental Content

Support Center